With the concern of Chinese pharmaceutical companies developing ... and global competition. “Our business model was designed to address the very concerns the industry is facing today—delivering ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

U.S. investors like Bain Capital Life Sciences and large pharmaceutical companies like ... than in the U.S. Buyers have figured out a business model to essentially import the drugs through ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q4 CY2024, with sales flat year on year at $594 million. Its ...

Agencies have always strived to build trust with their pharma clients, but that task is becoming more arduous as AI takes center stage.

It’s fair to say that the pharmaceutical ... in the pharma industry. MC: The usual licensing deals are not over, but we are bringing an additional mean to the business development arsenal.

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against other best drug stocks to buy now. Is ...